Back to Search Start Over

The effects of LL-37 on virulence factors related to the quorum sensing system of Pseudomonas aeruginosa .

Authors :
Xiao Q
Luo Y
Shi W
Lu Y
Xiong R
Wu X
Huang H
Zhao C
Zeng J
Chen C
Source :
Annals of translational medicine [Ann Transl Med] 2022 Mar; Vol. 10 (6), pp. 284.
Publication Year :
2022

Abstract

Background: Antimicrobial peptides (AMPs) have shown promise in the treatment of multi-resistant pathogens. It was therefore of interest to analyze the effects of the AMP LL-37 on the regulation of several virulence factors related to the quorum sensing (QS) system of Pseudomonas aeruginosa (P. aeruginosa) in vitro .<br />Methods: The minimum inhibitory concentration (MIC) was evaluated by the micro broth dilution method. The expression of QS-related and QS-regulated virulence factor genes was also evaluated. Exotoxin A activity was measured with the nicotinamide adenine dinucleotide (NAD) (Coenzyme I) method; Elastase activity was detected with the elastin-Congo red (ECR) method; Pyocyanin detection was performed using the chloroform extraction method. The effects of LL-37 were assessed by measuring the expression changes of the virulence protein-encoding genes of the strains with quantitative polymerase chain reaction (PCR).<br />Results: The MIC of LL-37 against both P. aeruginosa reference strain (ATCC 15692 PAO1) and PA- Δ lasI/rhII was therefore determined to be 256 µg/mL. LL-37 at sub-minimum inhibitory concentrations (sub-MICs) had no significant effects on P. aeruginosa bacterial growth (P>0.05), but significantly downregulated the expression of all 3 virulence factors.<br />Conclusions: Interestingly, this effect appeared to be dose-related. These findings suggest that LL-37 could be a potential candidate for QS inhibition against bacterial infection and may have significant clinical potential in the treatment of P. aeruginosa biofilms.<br />Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-617/coif). The authors have no conflicts of interest to declare.<br /> (2022 Annals of Translational Medicine. All rights reserved.)

Details

Language :
English
ISSN :
2305-5839
Volume :
10
Issue :
6
Database :
MEDLINE
Journal :
Annals of translational medicine
Publication Type :
Academic Journal
Accession number :
35434009
Full Text :
https://doi.org/10.21037/atm-22-617